Twelve months clinical outcomes of “Nano-crush technique” for the treatment of bifurcation lesions using ultra-thin (60 μm) sirolimus-eluting

Provisional stenting is preferred for bifurcation lesion however, certain anatomical substrate does require two stents as a part of dedicated stent technique. Here, the present study evaluated outcomes of ultra-thin (60 μm) Supra family sirolimus-eluting stent (SES) for dedicated bifurcation lesions using Nano-crush technique at 12 months angiographic follow-up

Twelve months clinical outcomes of “Nano-crush technique” for the treatment of bifurcation lesions using ultra-thin (60 μm) sirolimus-eluting – Minerva Cardiology and Angiology 2022 Feb 25 – Minerva Medica – Riviste

SUPRAFLEX CRUZ NEVO

Sirolimus-eluting cobalt chromium coronary stent system. SUPRAFLEX CRUZ NEVO combines…

Read More >